International platform for sharing cardiovascular data launched by euCanSHare
McGill's Professor Bartha Maria Knoppers to co-lead the work package on ethics and interoperability.
Tri-Agency Research Data Management Policy
On March 15, Canada鈥檚 three federal research funding agencies鈥攖he Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC) and the Social Sciences and Humanities Research Council (SSHRC) launched the Tri-Agency Research Data Management Policy (鈥淩DM Policy鈥�).
New Digital Research Services Team and Website
McGill鈥檚 researchers are increasingly reliant on the production, sharing and management of large amounts of data to generate knowledge. Regardless of the research discipline, scope and scale of the research activities, or technological proficiency, access to digital infrastructure has become a fundamental need.
Government of Canada funds McGill聽research on聽contaminants in aquatic ecosystems
Microplastics are tiny pieces of plastic that are microscopic and up to 5 millimetres in size. McGill research project aims to provide聽an understanding of how these contaminants聽end up in Canadian aquatic environments and what impacts they have.聽
McGill leads in urgent virus variant research network
Experts across Canada, including researchers at McGill, are working to understand the impact of COVID-19 virus variants of concern on the health of Canadians and our public health measures.
McGill and Genome Canada announce new Canadian SARS-CoV-2 Data Portal
A Made-in-Canada data solution to support the Government of Canada Variants of Concern Strategy
Professor Nancy Ross Appointed Vice-Principal, Research, at Queen鈥檚 University
After nearly 5 years as McGill鈥檚 Associate Vice-Principal, Research and Innovation (AVP-RI), Professor Nancy Ross is leaving McGill to join Queen鈥檚 University as Vice-Principal, Research. She will begin her appointment on August 1, 2021.
McGill to partner with CCRM in commercializing regenerative medicine
香蕉视频 announced today it has concluded an agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to provide McGill-based startup companies with the benefit of CCRM鈥檚 market-leading business intelligence and experience.
$110M for Nine Innovative McGill Research Projects
Read the story in the McGill Reporter
Read the McGill聽news release
Marc Rousseau joins McGill as Director, Research Software
Research and Innovation and IT Services are pleased to welcome Marc Rousseau to the role of Director, Research Software / Directeur du Logiciel de Recherche. In this new role, Rousseau provides support and advice to the McGill research community on software, from grant applications to the implementation of research activities.
Diamond Therapeutics Signs Agreement with 香蕉视频 for Research on Low-Dose LSD
TORONTO,聽Feb. 4, 2021聽/CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement with聽香蕉视频聽for the exclusive use of Dr.聽Gabriella Gobbi's聽groundbreaking studies with lysergic acid diethylamide (LSD), its mechanism of action on the brain, and its potential for use at low doses in the treatment of mental health disorders.聽
Four McGill projects receive SSHRC Partnership Engage Grants
SSHRC invests over $80k in new McGill research projects through the Partnership Engage Grants competition, two of which are directly related to COVID-19 research.
Major European grant backs McGill research on rare condition
The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an international research collaboration specific to the ultra-rare genetic disease, Schinzel-Giedion Syndrome (SGS).
McGill team wins grant to study 鈥榯rained immunity鈥� with Japanese researchers
Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening McGill鈥檚 relationship with Japan鈥檚 RIKEN institute.
By Junji Nishihata
Reminder: Canada Research Continuity Emergency Fund (CRCEF)
This is a reminder to all principal investigators to complete their Canada Research Continuity Emergency Fund Stage 3 claims as soon as possible.